These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 8569179

  • 1. Messenger RNA for urokinase plasminogen activator is expressed in myofibroblasts adjacent to cancer cells in human breast cancer.
    Nielsen BS, Sehested M, Timshel S, Pyke C, Danø K.
    Lab Invest; 1996 Jan; 74(1):168-77. PubMed ID: 8569179
    [Abstract] [Full Text] [Related]

  • 2. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R, Schaaf A.
    Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
    [Abstract] [Full Text] [Related]

  • 3. Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas.
    Nielsen BS, Rank F, López JM, Balbin M, Vizoso F, Lund LR, Danø K, López-Otín C.
    Cancer Res; 2001 Oct 01; 61(19):7091-100. PubMed ID: 11585740
    [Abstract] [Full Text] [Related]

  • 4. Stromal cells associated with early invasive foci in human mammary ductal carcinoma in situ coexpress urokinase and urokinase receptor.
    Nielsen BS, Rank F, Illemann M, Lund LR, Danø K.
    Int J Cancer; 2007 May 15; 120(10):2086-95. PubMed ID: 17290405
    [Abstract] [Full Text] [Related]

  • 5. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
    Biermann JC, Holzscheiter L, Kotzsch M, Luther T, Kiechle-Bahat M, Sweep FC, Span PN, Schmitt M, Magdolen V.
    Int J Mol Med; 2008 Feb 15; 21(2):251-9. PubMed ID: 18204793
    [Abstract] [Full Text] [Related]

  • 6. Expression of plasminogen activator inhibitors type 1 and type 3 and urokinase plasminogen activator protein and mRNA in breast cancer.
    Castelló R, Landete JM, España F, Vázquez C, Fuster C, Almenar SM, Ramón LA, Radtke KP, Estellés A.
    Thromb Res; 2007 Feb 15; 120(5):753-62. PubMed ID: 17258797
    [Abstract] [Full Text] [Related]

  • 7. In situ stromal expression of the urokinase/plasmin system correlates with epithelial dysplasia in colorectal adenomas.
    Sordat I, Chaubert P, Protiva P, Guillou L, Mazzucchelli L, Saraga E, Benhattar J, Trân-Thang C, Blum AL, Dorta G, Sordat B.
    Am J Pathol; 1997 Jan 15; 150(1):283-95. PubMed ID: 9006343
    [Abstract] [Full Text] [Related]

  • 8. Cellular localization of urokinase-type plasminogen activator, its inhibitors, and their mRNAs in breast cancer tissues.
    Umeda T, Eguchi Y, Okino K, Kodama M, Hattori T.
    J Pathol; 1997 Dec 15; 183(4):388-97. PubMed ID: 9496254
    [Abstract] [Full Text] [Related]

  • 9. Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies.
    Carriero MV, Franco P, Del Vecchio S, Massa O, Botti G, D'Aiuto G, Stoppelli MP, Salvatore M.
    Cancer Res; 1994 Oct 15; 54(20):5445-54. PubMed ID: 7923178
    [Abstract] [Full Text] [Related]

  • 10. Transforming growth factor-beta stimulates urokinase expression in tumor-associated macrophages of the breast.
    Hildenbrand R, Jansen C, Wolf G, Böhme B, Berger S, von Minckwitz G, Hörlin A, Kaufmann M, Stutte HJ.
    Lab Invest; 1998 Jan 15; 78(1):59-71. PubMed ID: 9461122
    [Abstract] [Full Text] [Related]

  • 11. In situ gene expression of urokinase-type plasminogen activator and its receptor in transitional cell carcinoma of the human bladder.
    Bhuvarahamurthy V, Schroeder J, Denkert C, Kristiansen G, Schnorr D, Loening SA, Jung K, Staack A.
    Oncol Rep; 2004 Oct 15; 12(4):909-13. PubMed ID: 15375521
    [Abstract] [Full Text] [Related]

  • 12. Expression of matrix metalloprotease-9 in vascular pericytes in human breast cancer.
    Nielsen BS, Sehested M, Kjeldsen L, Borregaard N, Rygaard J, Danø K.
    Lab Invest; 1997 Oct 15; 77(4):345-55. PubMed ID: 9354769
    [Abstract] [Full Text] [Related]

  • 13. Differential gene expression of urokinase-type plasminogen activator and its receptor in human renal cell carcinoma.
    Bhuvarahamurthy V, Schroeder J, Kristiansen G, Roigas J, Denkert C, Johannsen M, Lein M, Loening SA, Schnorr D, Jung K, Staack A.
    Oncol Rep; 2005 Sep 15; 14(3):777-82. PubMed ID: 16077991
    [Abstract] [Full Text] [Related]

  • 14. Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasminogen activator system promoting tumor cell invasion.
    Quemener C, Gabison EE, Naïmi B, Lescaille G, Bougatef F, Podgorniak MP, Labarchède G, Lebbé C, Calvo F, Menashi S, Mourah S.
    Cancer Res; 2007 Jan 01; 67(1):9-15. PubMed ID: 17210677
    [Abstract] [Full Text] [Related]

  • 15. Plasminogen activator system localization in 60 cases of ductal carcinoma in situ.
    Hurd TC, Sait S, Kohga S, Winston J, Martinick M, Saxena R, Lankes H, Markus G, Harvey S, Gibbs JF.
    Ann Surg Oncol; 2007 Nov 01; 14(11):3117-24. PubMed ID: 17701256
    [Abstract] [Full Text] [Related]

  • 16. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
    Han B, Nakamura M, Zhou G, Ishii A, Nakamura A, Bai Y, Mori I, Kakudo K.
    Int J Oncol; 2006 Apr 01; 28(4):807-14. PubMed ID: 16525628
    [Abstract] [Full Text] [Related]

  • 17. Urokinase plasminogen activator is localized in stromal cells in ductal breast cancer.
    Nielsen BS, Sehested M, Duun S, Rank F, Timshel S, Rygaard J, Johnsen M, Danø K.
    Lab Invest; 2001 Nov 01; 81(11):1485-501. PubMed ID: 11706057
    [Abstract] [Full Text] [Related]

  • 18. Co-expression of urokinase with haptoglobin in human carcinomas.
    Harvey S, Kohga S, Sait SN, Markus G, Hurd TC, Martinick M, Geradts J, Saxena R, Gibbs JF.
    J Surg Res; 2009 Apr 01; 152(2):189-97. PubMed ID: 19101688
    [Abstract] [Full Text] [Related]

  • 19. Heregulin regulation of urokinase plasminogen activator and its receptor: human breast epithelial cell invasion.
    Mazumdar A, Adam L, Boyd D, Kumar R.
    Cancer Res; 2001 Jan 01; 61(1):400-5. PubMed ID: 11196194
    [Abstract] [Full Text] [Related]

  • 20. Direct evidence of the importance of stromal urokinase plasminogen activator (uPA) in the growth of an experimental human breast cancer using a combined uPA gene-disrupted and immunodeficient xenograft model.
    Frandsen TL, Holst-Hansen C, Nielsen BS, Christensen IJ, Nyengaard JR, Carmeliet P, Brünner N.
    Cancer Res; 2001 Jan 15; 61(2):532-7. PubMed ID: 11212246
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.